Merck & Company Inc (MRK)

Return on assets (ROA)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands 17,117,000 12,148,000 13,736,000 2,306,000 365,000 4,608,000 3,111,000 13,030,000 14,519,000 15,260,000 16,579,000 14,180,000 13,049,000 7,197,000 5,571,000 7,028,000 7,068,000 11,518,000 10,478,000 10,146,000
Total assets US$ in thousands 117,106,000 117,532,000 112,630,000 105,849,000 106,675,000 106,727,000 104,469,000 107,796,000 109,160,000 107,081,000 107,095,000 106,668,000 105,694,000 93,494,000 90,688,000 90,847,000 91,588,000 89,800,000 90,615,000 84,913,000
ROA 14.62% 10.34% 12.20% 2.18% 0.34% 4.32% 2.98% 12.09% 13.30% 14.25% 15.48% 13.29% 12.35% 7.70% 6.14% 7.74% 7.72% 12.83% 11.56% 11.95%

December 31, 2024 calculation

ROA = Net income (ttm) ÷ Total assets
= $17,117,000K ÷ $117,106,000K
= 14.62%

The return on assets (ROA) of Merck & Company Inc has displayed fluctuations over the provided periods. The ROA percentage stood at 11.95% as of March 31, 2020, and decreased slightly to 11.56% by June 30, 2020. Subsequently, there was an increase in ROA to 12.83% by September 30, 2020. However, by December 31, 2020, the ROA decreased notably to 7.72%.

There was a marginal increase in ROA in the following quarter, reaching 7.74% by March 31, 2021. The trend continued downward, with ROA decreasing to 6.14% by June 30, 2021. The ROA showed a slight improvement by September 30, 2021, at 7.70%, and further increased to 12.35% by December 31, 2021.

The trend improved significantly in the following periods with ROA percentages of 13.29% as of March 31, 2022, and 15.48% by June 30, 2022. Although there was a slight dip to 14.25% by September 30, 2022, the ROA remained relatively high. By December 31, 2022, the ROA stood at 13.30%.

In the subsequent quarters, there was a decline in ROA, with percentages dropping to 12.09% by March 31, 2023, and significantly lower at 2.98% by June 30, 2023. The ROA showed a slight improvement at 4.32% by September 30, 2023, but decreased notably to 0.34% by December 31, 2023.

The trend reversed in the following periods, with ROA increasing to 2.18% by March 31, 2024, and significantly improving to 12.20% by June 30, 2024. By September 30, 2024, the ROA stood at 10.34% and further increased to 14.62% by December 31, 2024.

Overall, the ROA of Merck & Company Inc has shown variability over the time periods provided, experiencing fluctuations but displaying an overall increasing trend by the end of the data series.


See also:

Merck & Company Inc Return on Assets (ROA) (Quarterly Data)